
NIH opens Phase II coronavirus trial with Gilead drug at University of Nebraska
The randomized, placebo-controlled study of Gilead's remdesivir has been posted online and has enrolled the first patient, one of the passengers on a quarantined cruise ship docked off of Yokohama, Japan, who was repatriated to the U.S.